Exchange: NASDAQ·Updated 11:48 AM EDT
NXTC logo

NXTC Nextcure Inc

$7.37
$0.02
(0.27%)
Today
Reported EarningsAug 6
Mkt Cap$33.64M
Vol22,187.00

About NXTC

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.
39

Bearish Sentiment

How do you feel about NXTC?

Advertisement|Remove ads.